Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
People heavily infected with Loa loa can suffer brain injury after ivermectin. Measuring microfilarial density first, and deferring the few at risk, has made river blindness treatment safer.
Ivermectin kills scabies mites but not their eggs, so a second dose at day 14 is timed to catch newly hatched mites before they reproduce.
Standard ivermectin doses scale with body weight, but that formula was built on lean study populations. In obesity, the math breaks down in ways worth understanding.
A landmark head-to-head trial suggests moxidectin suppresses the parasite behind river blindness longer than ivermectin, though it isn't a wholesale replacement yet.
Topical ivermectin kills lice but not their eggs—yet clinical trials show it still breaks the infestation cycle. Here's the evidence and how it compares with permethrin.
Crusted (Norwegian) scabies in immunocompromised patients needs several ivermectin doses over weeks, not one. Here is the biology and evidence behind why.
A single ivermectin dose cures most strongyloides infections, but in immunosuppressed patients the parasite's internal life cycle can outrun it—here's the biology and the evidence behind extended courses.
Strongyloides stercoralis can replicate silently inside the human body for 50+ years via autoinfection. Here's the biology, the danger, and why ivermectin remains the treatment of choice.
Ivermectin's decades-long safety record rests on a specific biological gatekeeper. Here is how P-glycoprotein at the blood-brain barrier explains it.